{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:39:34Z","timestamp":1792813174413,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:00:00Z","timestamp":1470787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00296-016-3545-9","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T18:35:19Z","timestamp":1470854119000},"page":"1421-1429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus"],"prefix":"10.1007","volume":"36","author":[{"given":"Selin","family":"Ayta\u00e7","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi Deniz","family":"Batu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eule","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelda","family":"Bilginer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mualla","family":"\u00c7etin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Tuncer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"G\u00fcmr\u00fck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seza","family":"\u00d6zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,10]]},"reference":[{"key":"3545_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev-med-041610-134208","volume":"63","author":"GE Janka","year":"2012","unstructured":"Janka GE (2012) Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med 63:233\u2013246. doi: 10.1146\/annurev-med-041610-134208","journal-title":"Annu Rev Med"},{"key":"3545_CR2","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/art.11368","volume":"49","author":"R Dhote","year":"2003","unstructured":"Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, Dupond JL, Larroche C, Piette AM, Mechenstock D, Ziza JM, Arlaud J, Labussiere AS, Desvaux A, Baty V, Blanche P, Schaeffer A, Piette JC, Guillevin L, Boissonnas A, Christoforov B (2003) Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 49:633\u2013639. doi: 10.1002\/art.11368","journal-title":"Arthritis Rheum"},{"key":"3545_CR3","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S1473-3099(07)70290-6","volume":"7","author":"NG Rouphael","year":"2007","unstructured":"Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C (2007) Infections associated with haemophagocytic syndrome. Lancet Infect Dis 7:814\u2013822. doi: 10.1016\/S1473-3099(07)70290-6","journal-title":"Lancet Infect Dis"},{"key":"3545_CR4","first-page":"451","volume":"11","author":"JL Stephan","year":"1993","unstructured":"Stephan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM (1993) Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 11:451\u2013456","journal-title":"Clin Exp Rheumatol"},{"key":"3545_CR5","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jpeds.2012.11.081","volume":"162","author":"K Lehmberg","year":"2013","unstructured":"Lehmberg K, Pink I, Eulenburg C, Beutel K, Maul-Pavicic A, Janka G (2013) Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis. J Pediatr 162:1245\u20131251. doi: 10.1016\/j.jpeds.2012.11.081","journal-title":"J Pediatr"},{"key":"3545_CR6","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.38802","volume":"66","author":"F Minoia","year":"2014","unstructured":"Minoia F, Davi S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H, Gao YJ, Huasong Z, Kitoh T, Avcin T, Fischbach M, Frosch M, Grom A, Huber A, Jelusic M, Sawhney S, Uziel Y, Ruperto N, Martini A, Cron RQ, Ravelli A, Pediatric Rheumatology International Trials O, Childhood A, Rheumatology Research A, Pediatric Rheumatology Collaborative Study G, Histiocyte S (2014) Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol 66:3160\u20133169. doi: 10.1002\/art.38802","journal-title":"Arthritis Rheumatol"},{"key":"3545_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/01.bor.0000381996.69261.71","volume":"22","author":"AA Grom","year":"2010","unstructured":"Grom AA, Mellins ED (2010) Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol 22:561\u2013566. doi: 10.1097\/01.bor.0000381996.69261.71","journal-title":"Curr Opin Rheumatol"},{"key":"3545_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/gene.2012.3","volume":"13","author":"A Ravelli","year":"2012","unstructured":"Ravelli A, Grom AA, Behrens EM, Cron RQ (2012) Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun 13:289\u2013298. doi: 10.1038\/gene.2012.3","journal-title":"Genes Immun"},{"key":"3545_CR9","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1172\/JCI43157","volume":"121","author":"EM Behrens","year":"2011","unstructured":"Behrens EM, Canna SW, Slade K, Rao S, Kreiger PA, Paessler M, Kambayashi T, Koretzky GA (2011) Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest 121:2264\u20132277. doi: 10.1172\/JCI43157","journal-title":"J Clin Invest"},{"key":"3545_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3899\/jrheum.121233","volume":"40","author":"R Strippoli","year":"2013","unstructured":"Strippoli R, Caiello I, De Benedetti F (2013) Reaching the threshold: a multilayer pathogenesis of macrophage activation syndrome. J Rheumatol 40:761\u2013767. doi: 10.3899\/jrheum.121233","journal-title":"J Rheumatol"},{"key":"3545_CR11","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/art.33496","volume":"64","author":"R Strippoli","year":"2012","unstructured":"Strippoli R, Carvello F, Scianaro R, De Pasquale L, Vivarelli M, Petrini S, Bracci-Laudiero L, De Benedetti F (2012) Amplification of the response to Toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: implication for the pathogenesis of macrophage activation syndrome. Arthritis Rheum 64:1680\u20131688. doi: 10.1002\/art.33496","journal-title":"Arthritis Rheum"},{"key":"3545_CR12","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/art.37958","volume":"65","author":"SW Canna","year":"2013","unstructured":"Canna SW, Wrobel J, Chu N, Kreiger PA, Paessler M, Behrens EM (2013) Interferon-gamma mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice. Arthritis Rheum 65:1764\u20131775. doi: 10.1002\/art.37958","journal-title":"Arthritis Rheum"},{"key":"3545_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11926-014-0439-2","volume":"16","author":"M Zhang","year":"2014","unstructured":"Zhang M, Behrens EM, Atkinson TP, Shakoory B, Grom AA, Cron RQ (2014) Genetic defects in cytolysis in macrophage activation syndrome. Curr Rheumatol Rep 16:439. doi: 10.1007\/s11926-014-0439-2","journal-title":"Curr Rheumatol Rep"},{"key":"3545_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5152\/TurkPediatriArs.2015.3299","volume":"50","author":"K Barut","year":"2015","unstructured":"Barut K, Yucel G, Sinoplu AB, Sahin S, Adrovic A, Kasapcopur O (2015) Evaluation of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis: single center experience over a one-year period. Turk Pediatri Ars 50:206\u2013210. doi: 10.5152\/TurkPediatriArs.2015.3299","journal-title":"Turk Pediatri Ars"},{"key":"3545_CR15","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1002\/art.34661","volume":"64","author":"TD Bennett","year":"2012","unstructured":"Bennett TD, Fluchel M, Hersh AO, Hayward KN, Hersh AL, Brogan TV, Srivastava R, Stone BL, Korgenski EK, Mundorff MB, Casper TC, Bratton SL (2012) Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis. Arthritis Rheum 64:4135\u20134142. doi: 10.1002\/art.34661","journal-title":"Arthritis Rheum"},{"key":"3545_CR16","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3899\/jrheum.130690","volume":"41","author":"S Yokota","year":"2014","unstructured":"Yokota S, Imagawa T, Mori M, Miyamae T, Takei S, Iwata N, Umebayashi H, Murata T, Miyoshi M, Tomiita M, Nishimoto N, Kishimoto T (2014) Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan. J Rheumatol 41:759\u2013767. doi: 10.3899\/jrheum.130690","journal-title":"J Rheumatol"},{"key":"3545_CR17","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3899\/jrheum.140288","volume":"42","author":"S Yokota","year":"2015","unstructured":"Yokota S, Itoh Y, Morio T, Sumitomo N, Daimaru K, Minota S (2015) Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis under treatment with tocilizumab. J Rheumatol 42:712\u2013722. doi: 10.3899\/jrheum.140288","journal-title":"J Rheumatol"},{"key":"3545_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/RHU.0b013e3181a4f459","volume":"15","author":"A Zeft","year":"2009","unstructured":"Zeft A, Hollister R, LaFleur B, Sampath P, Soep J, McNally B, Kunkel G, Schlesinger M, Bohnsack J (2009) Anakinra for systemic juvenile arthritis: the Rocky Mountain Experience. J Clin Rheumatol 15:161\u2013164. doi: 10.1097\/RHU.0b013e3181a4f459","journal-title":"J Clin Rheumatol"},{"key":"3545_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fimmu.2012.00239","volume":"3","author":"L Chiossone","year":"2012","unstructured":"Chiossone L, Audonnet S, Chetaille B, Chasson L, Farnarier C, Berda-Haddad Y, Jordan S, Koszinowski UH, Dalod M, Mazodier K, Novick D, Dinarello CA, Vivier E, Kaplanski G (2012) Protection from inflammatory organ damage in a murine model of hemophagocytic lymphohistiocytosis using treatment with IL-18 binding protein. Front Immunol 3:239. doi: 10.3389\/fimmu.2012.00239","journal-title":"Front Immunol"},{"key":"3545_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.immuni.2013.06.019","volume":"39","author":"H Ohyagi","year":"2013","unstructured":"Ohyagi H, Onai N, Sato T, Yotsumoto S, Liu J, Akiba H, Yagita H, Atarashi K, Honda K, Roers A, Muller W, Kurabayashi K, Hosoi-Amaike M, Takahashi N, Hirokawa M, Matsushima K, Sawada K, Ohteki T (2013) Monocyte-derived dendritic cells perform hemophagocytosis to fine-tune excessive immune responses. Immunity 39:584\u2013598. doi: 10.1016\/j.immuni.2013.06.019","journal-title":"Immunity"},{"key":"3545_CR21","first-page":"67","volume":"Suppl 10","author":"CPG Bracaglia","year":"2015","unstructured":"Bracaglia CPG, Gatto A, Pardeo M, Lapeyre G, Raganelli L, Marasco E, Insalaco A, Ferlin W, Nelson R, de Min C, De Benedetti F (2015) Anti interferon gamma monoclonal antibody treatment in a child with NLRC4-related disease and severe hemophagocytic lymphohistiocytosis (HLH). Arthritis Rheumatol Suppl 10:67","journal-title":"Arthritis Rheumatol"},{"key":"3545_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.blre.2014.03.002","volume":"28","author":"GE Janka","year":"2014","unstructured":"Janka GE, Lehmberg K (2014) Hemophagocytic syndromes\u2013an update. Blood Rev 28:135\u2013142. doi: 10.1016\/j.blre.2014.03.002","journal-title":"Blood Rev"},{"key":"3545_CR23","first-page":"1133","volume":"34","author":"EM Behrens","year":"2007","unstructured":"Behrens EM, Beukelman T, Paessler M, Cron RQ (2007) Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 34:1133\u20131138","journal-title":"J Rheumatol"},{"key":"3545_CR24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","volume":"85","author":"S Sawhney","year":"2001","unstructured":"Sawhney S, Woo P, Murray KJ (2001) Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 85:421\u2013426","journal-title":"Arch Dis Child"},{"key":"3545_CR25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/rheumatology\/40.11.1285","volume":"40","author":"JL Stephan","year":"2001","unstructured":"Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM (2001) Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 40:1285\u20131292","journal-title":"Rheumatology (Oxford)"},{"key":"3545_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/art.22416","volume":"56","author":"J Bleesing","year":"2007","unstructured":"Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, Brunner HI, Griffin T, Graham TB, Sherry DD, Passo MH, Ramanan AV, Filipovich A, Grom AA (2007) The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 56:965\u2013971. doi: 10.1002\/art.22416","journal-title":"Arthritis Rheum"},{"key":"3545_CR27","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s10067-013-2227-1","volume":"32","author":"S Vilaiyuk","year":"2013","unstructured":"Vilaiyuk S, Sirachainan N, Wanitkun S, Pirojsakul K, Vaewpanich J (2013) Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review. Clin Rheumatol 32:899\u2013904. doi: 10.1007\/s10067-013-2227-1","journal-title":"Clin Rheumatol"},{"key":"3545_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/pr.2013.187","volume":"75","author":"CK Correll","year":"2014","unstructured":"Correll CK, Binstadt BA (2014) Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis. Pediatr Res 75:176\u2013183. doi: 10.1038\/pr.2013.187","journal-title":"Pediatr Res"},{"key":"3545_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11926-014-0489-5","volume":"17","author":"ZS Arici","year":"2015","unstructured":"Arici ZS, Batu ED, Ozen S (2015) Reviewing the recommendations for lupus in children. Curr Rheumatol Rep 17:17. doi: 10.1007\/s11926-014-0489-5","journal-title":"Curr Rheumatol Rep"},{"key":"3545_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/pbc.21564","volume":"51","author":"A Gupta","year":"2008","unstructured":"Gupta A, Tyrrell P, Valani R, Benseler S, Weitzman S, Abdelhaleem M (2008) The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 51:402\u2013404. doi: 10.1002\/pbc.21564","journal-title":"Pediatr Blood Cancer"},{"key":"3545_CR31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0002-9343(97)00136-8","volume":"103","author":"B Francois","year":"1997","unstructured":"Francois B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H (1997) Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 103:114\u2013120","journal-title":"Am J Med"},{"key":"3545_CR32","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.CCM.0000127779.24232.15","volume":"32","author":"R Strauss","year":"2004","unstructured":"Strauss R, Neureiter D, Westenburger B, Wehler M, Kirchner T, Hahn EG (2004) Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients\u2014a postmortem clinicopathologic analysis. Crit Care Med 32:1316\u20131321","journal-title":"Crit Care Med"},{"key":"3545_CR33","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0046-8177(88)80177-1","volume":"19","author":"S Suster","year":"1988","unstructured":"Suster S, Hilsenbeck S, Rywlin AM (1988) Reactive histiocytic hyperplasia with hemophagocytosis in hematopoietic organs: a reevaluation of the benign hemophagocytic proliferations. Hum Pathol 19:705\u2013712","journal-title":"Hum Pathol"},{"key":"3545_CR34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124\u2013131. doi: 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"3545_CR35","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/art.24883","volume":"60","author":"A Parodi","year":"2009","unstructured":"Parodi A, Davi S, Pringe AB, Pistorio A, Ruperto N, Magni-Manzoni S, Miettunen P, Bader-Meunier B, Espada G, Sterba G, Wright D, Magalhaes CS, Khubchandani R, Michels H, Woo P, Iglesias A, Guseinova D, Bracaglia C, Hayward K, Wouters C, Grom A, Vivarelli M, Fischer A, Breda L, Martini A, Ravelli A, Lupus Working Group of the Paediatric Rheumatology European S (2009) Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 60:3388\u20133399. doi: 10.1002\/art.24883","journal-title":"Arthritis Rheum"},{"key":"3545_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.semarthrit.2014.09.004","volume":"44","author":"MM Kostik","year":"2015","unstructured":"Kostik MM, Dubko MF, Masalova VV, Snegireva LS, Kornishina TL, Chikova IA, Likhacheva TS, Isupova EA, Glebova NI, Kuchinskaya EM, Balbotkina EV, Buchinskaya NV, Kalashnikova OV, Chasnyk VG (2015) Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis. Semin Arthritis Rheum 44:417\u2013422. doi: 10.1016\/j.semarthrit.2014.09.004","journal-title":"Semin Arthritis Rheum"},{"key":"3545_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, Arico M, Avcin T, Behrens EM, De Benedetti F, Filipovic L, Grom AA, Henter JI, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnik Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ, Paediatric Rheumatology International Trials Organisation tCA, Rheumatology Research Alliance tPRCSG, The Histiocyte S (2016) 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis 75:481\u2013489. doi: 10.1136\/annrheumdis-2015-208982","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3545_CR38","first-page":"111","volume":"29","author":"E Demirkaya","year":"2011","unstructured":"Demirkaya E, Ozen S, Bilginer Y, Ayaz NA, Makay BB, Unsal E, Erguven M, Poyrazoglu H, Kasapcopur O, Gok F, Akman S, Balat A, Cavkaytar O, Kaya B, Duzova A, Ozaltin F, Topaloglu R, Besbas N, Bakkaloglu A, Arisoy N, Ozdogan H, Bakkaloglu S, Turker T (2011) The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association. Clin Exp Rheumatol 29(1):111\u2013116","journal-title":"Clin Exp Rheumatol"},{"key":"3545_CR39","doi-asserted-by":"publisher","first-page":"e000161","DOI":"10.1136\/rmdopen-2015-000161","volume":"2","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, Arico M, Avcin T, Behrens EM, De Benedetti F, Filipovic A, Grom AA, Henter JI, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnik Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ (2016) Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. RMD Open 2:e000161. doi: 10.1136\/rmdopen-2015-000161","journal-title":"RMD Open"},{"key":"3545_CR40","doi-asserted-by":"publisher","first-page":"294041","DOI":"10.1155\/2015\/294041","volume":"2015","author":"G Granata","year":"2015","unstructured":"Granata G, Didona D, Stifano G, Feola A, Granata M (2015) Macrophage activation syndrome as onset of systemic lupus erythematosus: a case report and a review of the literature. Case Rep Med 2015:294041. doi: 10.1155\/2015\/294041","journal-title":"Case Rep Med"},{"key":"3545_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12969-015-0055-3","volume":"13","author":"V Boom","year":"2015","unstructured":"Boom V, Anton J, Lahdenne P, Quartier P, Ravelli A, Wulffraat NM, Vastert SJ (2015) Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Pediatr Rheumatol Online J 13:55. doi: 10.1186\/s12969-015-0055-3","journal-title":"Pediatr Rheumatol Online J"},{"key":"3545_CR42","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00296-010-1711-z","volume":"32","author":"S Singh","year":"2012","unstructured":"Singh S, Chandrakasan S, Ahluwalia J, Suri D, Rawat A, Ahmed N, Das R, Sachdeva MU, Varma N (2012) Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India. Rheumatol Int 32:881\u2013886. doi: 10.1007\/s00296-010-1711-z","journal-title":"Rheumatol Int"},{"key":"3545_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/08035320600649713","volume":"95","author":"E Cortis","year":"2006","unstructured":"Cortis E, Insalaco A (2006) Macrophage activation syndrome in juvenile idiopathic arthritis. Acta Paediatr 95:38\u201341. doi: 10.1080\/08035320600649713","journal-title":"Acta Paediatr"},{"key":"3545_CR44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/rheumatology\/keq218","volume":"50","author":"PM Miettunen","year":"2011","unstructured":"Miettunen PM, Narendran A, Jayanthan A, Behrens EM, Cron RQ (2011) Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology (Oxford) 50:417\u2013419. doi: 10.1093\/rheumatology\/keq218","journal-title":"Rheumatology (Oxford)"},{"key":"3545_CR45","first-page":"2120","volume":"28","author":"S Prahalad","year":"2001","unstructured":"Prahalad S, Bove KE, Dickens D, Lovell DJ, Grom AA (2001) Etanercept in the treatment of macrophage activation syndrome. J Rheumatol 28:2120\u20132124","journal-title":"J Rheumatol"},{"key":"3545_CR46","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10067-012-1998-0","volume":"31","author":"CI Lin","year":"2012","unstructured":"Lin CI, Yu HH, Lee JH, Wang LC, Lin YT, Yang YH, Chiang BL (2012) Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clin Rheumatol 31:1223\u20131230. doi: 10.1007\/s10067-012-1998-0","journal-title":"Clin Rheumatol"},{"key":"3545_CR47","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F Benedetti De","year":"2012","unstructured":"De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, Wouters C, Xavier R, Zemel L, Baildam E, Burgos-Vargas R, Dolezalova P, Garay SM, Merino R, Joos R, Grom A, Wulffraat N, Zuber Z, Zulian F, Lovell D, Martini A, Printo Prcsg (2012) Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med 367:2385\u20132395. doi: 10.1056\/NEJMoa1112802","journal-title":"N Engl J Med"},{"key":"3545_CR48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1546-0096-13-4","volume":"13","author":"MM Kostik","year":"2015","unstructured":"Kostik MM, Dubko MF, Masalova VV, Snegireva LS, Kornishina TL, Chikova IA, Isupova EA, Kuchinskaya EM, Glebova NI, Buchinskaya NV, Kalashnikova OV, Chasnyk VG (2015) Successful treatment with tocilizumab every 4\u00a0weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis. Pediatr Rheumatol Online J 13:4. doi: 10.1186\/1546-0096-13-4","journal-title":"Pediatr Rheumatol Online J"},{"key":"3545_CR49","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","volume":"367","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, Hofer M, Kallinich T, Oliveira SK, Uziel Y, Viola S, Nistala K, Wouters C, Cimaz R, Ferrandiz MA, Flato B, Gamir ML, Kone-Paut I, Grom A, Magnusson B, Ozen S, Sztajnbok F, Lheritier K, Abrams K, Kim D, Martini A, Lovell DJ, Printo Prcsg (2012) Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med 367:2396\u20132406. doi: 10.1056\/NEJMoa1205099","journal-title":"N Engl J Med"},{"key":"3545_CR50","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1177\/0961203309354906","volume":"19","author":"G Carvalheiras","year":"2010","unstructured":"Carvalheiras G, Anjo D, Mendonca T, Vasconcelos C, Farinha F (2010) Hemophagocytic syndrome as one of the main primary manifestations in acute systemic lupus erythematosus\u2014case report and literature review. Lupus 19:756\u2013761. doi: 10.1177\/0961203309354906","journal-title":"Lupus"},{"key":"3545_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12519-008-0018-6","volume":"4","author":"HS Zeng","year":"2008","unstructured":"Zeng HS, Xiong XY, Wei YD, Wang HW, Luo XP (2008) Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis. World J Pediatr 4:97\u2013101. doi: 10.1007\/s12519-008-0018-6","journal-title":"World J Pediatr"},{"key":"3545_CR52","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/art.38092","volume":"65","author":"S Ringold","year":"2013","unstructured":"Ringold S, Weiss PF, Beukelman T, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Nigrovic PA, Robinson AB, Vehe RK, American Collge of R (2013) 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Rheum 65:2499\u20132512. doi: 10.1002\/art.38092","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3545-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-016-3545-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3545-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:25:48Z","timestamp":1498335948000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-016-3545-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,10]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["3545"],"URL":"https:\/\/doi.org\/10.1007\/s00296-016-3545-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,10]]}}}